# PASITHEA THERAPEUTICS CORP (KTTAW)

> Institutional ownership reported to the SEC as of Q2 2026, from Form 13F filings. Source: https://holderbook.com/stocks/KTTAW/

- Reporting holders: 6
- Reported value: $3.2K
- Shares held by institutions: 491,812 of 33,414,448 outstanding
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Kepos Capital LP](https://holderbook.com/funds/1512020-kepos-capital-lp/) | $2.0K | 334,600 | 0.0% | 19 |
| [TWO SIGMA SECURITIES, LLC](https://holderbook.com/funds/1450144-two-sigma-securities-llc/) | $397 | 57,539 | 0.0% | 3 |
| [ARMISTICE CAPITAL, LLC](https://holderbook.com/funds/1601086-armistice-capital-llc/) | $345 | 50,000 | 0.0% | 20 |
| [Marex Group Ltd](https://holderbook.com/funds/1997464-marex-group-ltd/) | $223 | 25,000 | 0.0% | 11 |
| [SUSQUEHANNA INTERNATIONAL GROUP, LLP](https://holderbook.com/funds/1446194-susquehanna-international-group-llp/) | $216 | 24,293 | 0.0% | 1 |
| [Clear Street Group Inc.](https://holderbook.com/funds/1881567-clear-street-group-inc/) | $3 | 380 | 0.0% | 1 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q2 2026 | 6 | $3.2K |
| Q1 2026 | 5 | $5.5K |
| Q4 2025 | 4 | $6.8K |
| Q3 2025 | 5 | $7.7K |
| Q2 2025 | 5 | $8.8K |
| Q1 2025 | 6 | $9.6K |
| Q4 2024 | 5 | $23.5K |
| Q3 2024 | 5 | $23.8K |
| Q2 2024 | 5 | $12.7K |
| Q1 2024 | 5 | $8.7K |
| Q4 2023 | 5 | $29.9K |
| Q3 2023 | 7 | $13.2K |